<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3075259/" ref="ordinalpos=501&amp;ncbi_uid=2909419&amp;link_uid=PMC3075259" image-link="/pmc/articles/PMC3075259/figure/pone-0018636-g004/" class="imagepopup">Figure 4. <span class="highlight" style="background-color:">Pathway</span> diagram showing the hypothetical positions of the GBM survival associated genes MTR and CCNB1 in the glioblastoma p53 <span class="highlight" style="background-color:">pathway</span> [3]..  From: Data Integration Workflow for Search of Disease Driving Genes and Genetic Variants. </a></div><br /><div class="p4l_captionBody">KEGG annotates CCNB1 to belong to the p53 pathway together with CCNB2, CCNB3 and CDC2 [6]. In the KEGG p53 signaling pathway, these are regulated by the genes SFN, GADD45G, GADD45A and GADD45B, which constitute a subset of the p53 target genes. In the KEGG glioma pathway, G2 arrest impairment is annotated as one result of the altered p53 pathway activation [6].</div></div>